Spots Global Cancer Trial Database for Metabiomics Colon Cancer Clinical Research Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Metabiomics Colon Cancer Clinical Research Study
Official Title: Metabiomics Colon Cancer Clinical Research Study
Study ID: NCT02151123
Conditions
Interventions
Study Description
Brief Summary: The specific aim of the study is to determine the false negative rate of the Metabiomics Colon Polyp and Colorectal Cancer Assay for Cancer.
Detailed Description: The purpose of this study is to conduct clinical research to investigate the association of the gut microbiome with colonic neoplasia. In this case several types of gut microbiome samples will be collected from patients undergoing colectomy for colonic adenocarcinoma; those samples will be tested by Metabiomics Colon Polyp and Colorectal Cancer Assay and the percentage of false negative (test returns a negative for cancer) results determined.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Colorado School of Medicine Anschutz Medical Campus, Aurora, Colorado, United States
Contact Details
Name: Jon Vogel, MD
Affiliation: University of Colorado School of Medicine Anschutz Medical Campus
Role: PRINCIPAL_INVESTIGATOR
Name: Christopher Lieu, MD
Affiliation: University of Colorado School of Medicine Anschutz Medical Campus
Role: PRINCIPAL_INVESTIGATOR
Name: Patrick Gillevet, PhD
Affiliation: George Mason University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
